09

OUR ADVISORS

[ the Exceptional people that help guide us ]
+
+
Colossal

Expertise is in Colossal’s DNA.

Changing the world starts with assembling the right team. At Colossal, our core consists of highly published and well-respected industry leading scientists. It takes radical thinking to go against the grain and effect change. Our team pushes outside the boundaries of what is known to explore the possibilities of possibility.

Great minds
don’t always
think alike...
+

But that’s a gOOD thing!

At Colossal, we believe that a diverse group of wide-ranging leaders in science, technology, business, and conservation brings an excellent consensus of wisdom and guidance to our company.

ADVISORY BOARD
Advisors NUMBERS & STATISTICS
500+

Collective Patents

2K+

Published Papers

28

PhDs

Our team is made up of some of the world’s brightest minds and that’s no accident. When we set forth on our mission, we knew having a team capable of seeing the same future we envisioned was key. Collectively, our team has published over 2,000 papers and secured over 500 unique patents. All that knowledge and expertise spread across our team of just 28 PhDs is just the beginning. As we move closer to de-extinction more papers will be published, patents secured and breakthroughs made.

+
+
+
Advisors SCIENCE & TECHNOLOGY BOARD

Leadership

SCIENtific
Advisory Board

+

At Colossal we're bringing together the greatest minds and leaders in technology, translational medicine, chemical engineering, biotechnology, molecular genetics, and software along with ground-breaking entrepreneurs to help guide us on our path. Our team includes practicing physicians, researchers, authors, inventors, professors, and winners of the Anitschkow Prize, National Medal of Technology and Innovation, Breakthrough Prize in Life Sciences and the Harvey Prize.

+
Nobel Prize in Chemistry 2022 Laureate

Carolyn Bertozzi, Ph.D.

2022 Nobel Prize in Chemistry Laureate
Founder of the Bertozzi Group
Baker Family Director of Stanford ChEM-H

[ COLOSSAL SCIENTIFIC ADVISORY BOARD MEMBER ]

+

Professor Carolyn Bertozzi’s research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.

Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.

Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology.

She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.

The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of “bioorthogonal chemistry”, a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.

Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly.

+
[ Scientific ADVISORY BOARD ]
+

Austin Gallagher, Ph.D.

World Renowned Marine Biologist / Shark Expert
Founder of Beneath the Waves Group
Founder of Blueprint

[ COLOSSAL SCIENTIFIC ADVISORY BOARD MEMBER ]

Dr. Austin Gallagher is a globally-activated marine biologist and social entrepreneur, best known for his research on megafauna, particularly sharks. He is the founder of The Beneath the Waves Group, which controls six companies engaged in cutting-edge marine research and exploration, technology, climate solutions, and carbon finance. He serves as CEO to core asset Beneath the Waves Inc., a next-generation NGO research institute engaged in marine projects worldwide, with a focus on North America and The Caribbean. Gallagher’s approach combines research, private sector collaboration, local engagement, and media – to create effective partnerships.Dr. Gallagher has worked diligently studying and advocating for highly migratory species and their habitats around the world, directly supporting the protection of species and hundreds of thousands of square kilometers of ocean. He has served as the lead scientist on 50+ global scientific expeditions across six continents, and is broadly trained with expertise spanning large animal tracking, behavioral ecology, physiology, genetics, plant biology, and socioeconomics.

He has published over 100 scientific papers, spanning research on the migrations of ocean giants, blue carbon, deep-sea exploration, and marine policy, and sits on the Editorial Board of Endangered Species Research. He has forged dozens of firsts in the marine industry, ranging from the identification of new species and geographic records, to implementing new technologies to accelerate conservation solutions. In 2020, he partnered with wild tiger sharks to discover the world’s largest seagrass meadow, an area over 93,000 sq. km representing the ocean’s largest carbon sink, a discovery valued at over $400 billion. This discovery paved the way for his founding of Blueprint, a company focused on providing governments and corporations an end-to-end solution for blue carbon project management – from science to credits. Dr. Gallagher is regularly consulted by US Congress, international governments, and he has briefed and collaborated with over 10 Heads of State to prompt and develop legislation and policies to protect threatened ocean habitat, species, and the communities that depend on them. He is a National Geographic Explorer, Fellow of the Explorers Club, Fulbright Scholar, former Forbes 30 Under 30 winner, and is an Adjunct Professor at both The University of Exeter and Northeastern University.

+
[ Scientific ADVISORY BOARD ]
 
American Heart Association Fellow

Doris A. taylor,
ph.d.

Thought Leader in Regenerative Medicine
Founder of RegenMedix Consulting
Founder of Organamet Bio Inc.

[ COLOSSAL SCIENTIFIC ADVISORY BOARD MEMBER ]

+

Dr. Taylor is a dynamic innovator, scientist and entrepreneur and a global thought leader and speaker in regenerative medicine. She is recognized as a thought leader in biomanufacturing as evidenced by her recent service on a White House panel, has published over 180 papers, holds over 30 patents, and is the founder of multiple companies, one of which went public last year (MIRO;NASDAQ). She has trained hundreds of undergraduate, graduate, and post-graduate fellows worldwide in her laboratories in the U.S. and Europe. Although she held academic positions for over 20 years, she recently founded RegenMedix Consulting LLC to enable academic and commercial enterprises in the regenerative medicine space. In 2021, she founded a new biotech Organamet Bio Inc. to bioengineer personalized replacement hearts on demand. The latest breakthrough in that technology was featured on CNN in September 2022 (https://www.cnn.com/videos/tv/2022/09/15/cfc-gupta-taylor.cnn). Taylor is credited with the first functional scientific repair of an injured heart with stem cells in 1998. Her group further transformed the field of organ transplantation science in 2008 by developing a unique cell removal (decellularization) method that makes un-transplantable organs into usable scaffold frameworks for building new organs with stem cells. This was so revolutionary it was recognized as one of the “Top 10 Research Advances” by the American Heart Association and Taylor was nominated as one of “100 Most Influential People in the World” by Time Magazine. Next, she turned to disease prevention and has begun to develop “cellular signatures” of heart disease and aging that appear to differ by sex, race and ethnicity.

Dr. Taylor frequently appears as an expert on molecular biology, biobanking, cell therapy, women’s health, cardiac repair and organ transplantation in the public media. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Forbes, National Geographic, BBC Horizon, BBC News Health, ABC, NBC and CBS News, Associated Press, Good Morning America, the Oprah Winfrey Show, NOVA Science Now, PBS NOVA's Transplanting Hope, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, NPR’s On Being with Krista Tippet and most other worldwide media outlets. Taylor sits on numerous think tanks and international scientific committees including for the NIH, the FDA, the American Association of Blood Banks, and the Alliance for Regenerative Medicine. She serves as a member of the Leadership Advisory Committee for the Alliance for Regenerative Manufacturing Institute (ARMI) and sat on the international jury for the Institut de France LeFoulon-Delalande Foundation Grand Prix which is awarded annually to individuals making worldwide contributions to cardiovascular medicine. Dr. Taylor earned a B.S. from Mississippi University for Women (MUW) and a Ph.D. from UT Southwestern Medical Center. She is appointed as a Fellow of the American Heart Association, American College of Cardiology, and European Society for Cardiology. She was awarded an honorary Doctor of Science degree by MUW and the national Distinguished Alumnus Award by the American Association of State Colleges and Universities. In 2019 she was elected as a Senior member of the National Academy of Inventors and in 2020, was elected as a fellow to the American Institute for Medical and Biological Engineering. Her motto is “Build the Future of Medicine Today.”

+
[ Scientific ADVISORY BOARD ]
 
THE EXPLORERS CLUB MEDAL
2019 RECIPIENT

Kenneth Lacovara,
ph.d.

World-Renowned Paleontologist / Explorer
2019 Recipient of The Explorers Club Medal
Discovered the Dreadnoughtus Dinosaur

[ COLOSSAL SCIENTIFIC ADVISORY BOARD MEMBER ]

+

Dr. Kenneth Lacovara has unearthed some of the largest dinosaurs ever to walk the earth, including the massive 65-ton Dreadnoughtus, which appeared in the recent film Jurassic World: Dominion. He is a recipient of The Explorers Club Medal, the club’s highest honor, previously awarded to pioneers such as Sir Edmund Hillary, Jane Goodall, and Neil Armstrong. His TED Talk has been viewed by over four million people, and his book, Why Dinosaurs Matter, published by Simon & Schuster, is a winner of the Nautilus Book Prize.

Lacovara’s discoveries have landed him three times in Discover magazine’s 100 Top Science Stories of the Year and he has appeared in 17 television documentaries. Currently, he is researching the extinction of the dinosaurs. He is the founding dean of the School of Earth & Environment at Rowan University, and is executive director of the Edelman Fossil Park & Museum, where he and his team are building a $85M museum designed to connect people to deep time, the contingencies of natural history, and the fragility of our planet.

+
[ Scientific ADVISORY BOARD ]
 

Thomas Hildebrandt,
ph.d.

World Leader in Artificial Reproduction
Founder of BioRescue for Northern White Rhinos
European College of Zoological Medicine

[ COLOSSAL SCIENTIFIC ADVISORY BOARD MEMBER ]

+

Dr Thomas Hildebrandt is a professor and chair of wildlife reproduction medicine at the Freie Universitaet of Berlin. Prof Hildebrandt and his team are world leaders in using artificial reproduction to breed rare and endangered animals such as elephants, rhinos and giant pandas. He was a founding member of the subspecialty Zoo Health Management as part of the European College of Zoological Medicine (ECZM) and served as Credential Committee of the European College of Zoological Medicine the board of veterinary specialists from 2011 to 2014.

He holds the honorary appointment of Professiorial Fellow of biosciences at the University of Melbourne (2012 to 2022) and is also the Head of the Department of Reproduction Management at the Leibniz Institute for Zoo and Wildlife Research in Berlin. Prof Hildebrandt is well known internationally for his research on assisted reproduction in wildlife and especially the rescue project of the northern white rhinoceros (BioRescue) raised global interest. He is recipient of numerous awards. For example he received the Conservation Legacy Award in 2015 for his substantial impact to conservation projects in the USA.

+
[ Scientific ADVISORY BOARD ]
+
Advisors EXECUTIVE BOARD

Leadership

Executive
Advisory Board

+

We’re also partnering with leaders in critical industry sectors who have deep experience and decades of relationships with Fortune 500 leaders and beyond. This board ensures that we ethically meet our business objectives so our research and development into biosciences can continue to benefit humankind indefinitely.

+
 
+

Robert Nelsen

Co-founder and Managing Director, ARCH Venture Partners

[ COLOSSAL EXECUTIVE ADVISORY BOARD MEMBER ]

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He has played a significant role in the creation, early sourcing, financing, and development of more than 100 companies, including over 39 which have reached valuations exceeding $1 billion. Mr. Nelsen is focused on generating new ideas for disruptive technologies or business models and partnering with founding management teams and entrepreneurs to execute on these visions by advancing novel platform technologies with the overarching goal of improving health care and outcomes. Recent successes include founding National Resilience to transform pharma manufacturing in the U.S., Vir Biotechnology’s COVID-19 antibody therapy, IPOS for Prime Medicine, Beam Therapeutics and Sana Biotechnology.

Notable early-stage investments include Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), Juno Therapeutics (sold to Celgene for $11.9 billion) and GRAIL (Sold to Illumina for $10 billion). Other prominent biotechnology and life sciences company investments include Array BioPharma (sold to Pfizer for $11.4 billion), Receptos (sold to Celgene for $7.2 billion), Sage Therapeutics (SAGE), Denali Therapeutics (DNLI), Karuna Therapeutics (KRTX), BEAM, Prime Medicine, Lyell Immunopharma, Editas (EDIT), Agios Pharmaceuticals (AGIO), Ikaria, deCODE Genetics (sold to Amgen), 10x Genomics, and Semma Therapeutics (sold to Vertex Pharmaceuticals), among others. Mr. Nelsen is a director of VIR, SANA, National Resilience, Lyell Immunopharma, and serves as Chairman of Hua Medicine, among others. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.

[ Executive ADVISORY BOARD ]
+
 

Richard Garriott

President of The Explorers Club
Founding Father of the Videogame Industry
Commercial Spaceflight Pioneer

[ COLOSSAL EXECUTIVE ADVISORY BOARD MEMBER ]

+

Richard Garriott de Cayeux is an avid explorer and creator. His explorations have taken him on expeditions from pole to pole and across all seven continents, he has orbited the earth aboard the ISS and been on numerous deep submersible voyages including the Challenger Deep. Richard currently serves as the President of The Explorers Club.

His work on expeditions commonly includes the search for extremophiles, environmental impacts and educational outreach. He has used exploration as the inspiration for much of his creations such as the virtual worlds he created through his 40-year career as a principal shaper of the video gaming industry.

Richard is also a founding father of the video game industry. He has been inducted into the Computer Gaming Hall of Fame and has received the Industry Lifetime Achievement Award. He is credited with creating the now-ubiquitous term “avatar” for one’s virtual self and the category of massively multiplayer games (MMORPGs).

Richard is also a principal shaper of commercial human spaceflight. He co-founded Space Adventures, the company which arranged the space flights for the first seven private citizens live aboard the International Space Station. The son of a NASA astronaut, he became the first second-generation astronaut and remains a key leader in civilian and commercial space as an investor and board member of institutions such as the X-Prize Foundation, Space Adventures, Space X and ZeroG Corp.

+
[ Executive ADVISORY BOARD ]
 
+

ERIK ANDERSON

Founder and CEO of WestRiver Group
Chairman and CEO of Singularity Group
Vice Chairman of Callaway Golf Company
Former Founder and CEO of Topgolf

[ COLOSSAL EXECUTIVE ADVISORY BOARD MEMBER ]

Erik Anderson is a global innovation leader, investor and philanthropist. He is Founder and CEO of WestRiver Group, a thematically-driven investment platform that manages funds and builds companies in the global innovation economy. Anderson has received the Ernst & Young Entrepreneur of the Year Award, was named by Goldman Sachs as one of the Top 100 Most Intriguing Entrepreneurs and was also awarded the Transformative CEO Award by The CEO Forum Group. Early in his career, Seattle’s Puget Sound Business Journal recognized Anderson as one of the Top “40 under 40” young achievers and emerging leaders.

He is also Chief Executive Officer of the DCRB+ Special Purpose Acquisition Companies (SPACs), which seek to identify impactful companies with scalable solutions to decarbonize the global economy.

He currently serves on the Board of Directors for Hyzon Motors Inc., a zero-emissions, hydrogen-powered commercial vehicle company with leading fuel cell technology, as well as serving on the board of Solid Power, an industry-leading developer of all-solid-state battery cells

Anderson became Vice Chairman of Callaway Golf Company in March 2021. Prior to Callaway, he served as the Executive Chairman of Topgolf Entertainment Group. Under his leadership, Topgolf became one of the fastest-growing sports and entertainment brands in the world. In 2020, he was ranked by Golf Inc. as the No. 4 Most Powerful Person in the Golf Industry and was No. 3 in 2019 and 2018

[ Executive ADVISORY BOARD ]
+
Advisors CONSERVATION BOARD

Leadership

CONSERVATION
Advisory Board

+

The ultimate aim of de-extinction and rewilding is to restore delicate, ecosystems back to healthier, more planet-friendly states. Thus it’s critical that we partner with some of the sharpest and most experienced minds in conservation today. For their leadership and advisement, we are forever grateful.

+
 
TV Show Host & Creator

FORREST GALANTE

Founder of Phantasticus Pictures
Rediscovered 8 Species Believed to be Extinct
Renowned Adventurer / Field Biologist

[ COLOSSAL CONSERVATION ADVISORY BOARD MEMBER ]

+

Galante is wildlife biologist and owner of Phantasticus Pictures (a wildlife media company) and host of several successful wildlife tv shows. His focus is on animals facing extinction, whether it be mislabeling or because of human wildlife conflicts. After growing up in the bush of Zimbabwe as the son of a safari business owner, Galante and his family fled to the United States where he finished his formal education. As a young and hungry biologist with a degree from the University of California, Santa Barbara, Galante pursued a career in high-risk wildlife biology fieldwork. Galante’s hands-on approach to wildlife, passion for nature and extraordinary background in tracking animals eventually led to the development of his own television show, Extinct or Alive, on Animal Planet. The show followed Galante as he traveled the globe searching for animals he believed have wrongfully been deemed extinct.

Since 2018, Galante has captured evidence of the existence of eight animals once believed to be extinct. Galante continues to conduct field expeditions and surveys, working not just with believed-extinct animals but also with a wide range of other wildlife. His mission is to inspire and educate people about animals and adventure through the media, including hosting a wide range of programs on Discovery, on-camera expert interviews, and production of his own wildlife and natural history shows via his production company. He also communicates his mission through his public speaking at Congress, the United Nations and via his active social media presence. Galante is the most notable name on the topic of animals wrongfully being labeled extinct and brings a unique and experienced field perspective to the topic of de-extinction.

[ Conservation ADVISORY BOARD ]
 
the Order of the
Golden Ark
Commander of the
British empire (CBE)

Iain Douglas Hamilton, Ph.D., CBE

World-Renowned African Elephant Expert
Founder of Save the Elephants
Order of the Golden Ark and CBE Recipient

[ COLOSSAL CONSERVATION ADVISORY BOARD MEMBER ]

+

Iain Douglas-Hamilton, D.Phil., CBE, is an authority on elephant behaviour and conservation. He attended Gordonstoun School, and later Oxford University where he earned a degree in Zoology and a D.Phil studying the Ecology and Behaviour of the African Elephant. His work in the 1960s paved the way for much of today’s understanding of elephants and current conservation practices. During the 1970s, he investigated the status of elephants throughout Africa and was the first to alert the world to the ivory poaching crisis. He chronicled the diminution of Africa’s elephant population by half between 1979 and 1989 and was instrumental in bringing about the world ivory trade ban. In 1993, Douglas-Hamilton founded Save the Elephants (STE) a charity dedicated specifically to elephants. Since that time Save the Elephants has conducted research on elephants across Africa and has increased public awareness of the many dangers that threaten elephants and the habitats in which they live. Fundamental to his work at STE, Douglas-Hamilton pioneered GPS tracking of elephants in Africa, which has become a standard and widely emulated survey technique; it also guides the deployment of rangers to protect vulnerable and key elephant populations.

Douglas-Hamilton and his wife, Oria, have co-authored two award-winning books, Among the Elephants (1975) and Battle for the Elephants (1992), and have made several television films. Dr. Iain Douglas-Hamilton was awarded the 2010 Indianapolis Prize, one of the world’s leading awards for animal conservation. In 2013, The Elephant Crisis Fund (a joint initiative between Save the Elephants and San Francisco based NGO Wildlife Conservation Network) was established to confront the threat to elephants by supporting the most urgent, important and catalytic projects across the crisis to stop the killing, stop the trafficking and end the demand for ivory. In October 2014, he was presented with the George B. Rabb Conservation Medal by the Chicago Zoological Society (CZS) for his authoritative work to benefit African elephants. In 2015, he was awarded the Commander of the British Empire and was presented the Lifetime Achievement Award by San Diego Zoological Society with most recently being awarded the Tanzanian Wildlife Research Institute’s (TAWIRI) Tanzania Wildlife Research Award for his lifelong devotion to elephants. Currently, he is focused on winning hearts and minds to help reduce the demand for ivory and focus on understanding elephants' reasons for movements and their deep history in time.

+
[ Conservation ADVISORY BOARD ]
 
22nd director of the
U.s. Fish & wildlife service

Honorable Aurelia Skipwith, J.D.

22nd Director of the U.S. Fish and Wildlife Service
Co-Founder of AVC Global
Former CEO of the Intl Order of T. Roosevelt

[ COLOSSAL CONSERVATION ADVISORY BOARD MEMBER ]

+

The Honorable Aurelia Skipwith Giacometto is the General Counsel and co-founder of AVC Global. A premier logistics company that works with national governments to secure the entry and sale of pharmaceuticals into their countries. She recently served as CEO of the International Order of T. Roosevelt, a startup not-for-profit conservation organization, where she was responsible for establishing their infrastructure and developing their programs that aligned with the mission to preserve nature’s precious resources through conservation, education, and ingenuity through science and stewardship. Aurelia has over 15 years of experience in regulatory compliance in various fields of agriculture, environmental stewardship, and management of fish and wildlife populations. She worked as a biologist developing sustainable crops at Monsanto, and as a legal counsel at Alltech Inc., an all-natural livestock feed operation.

In 2017, she was appointed by President Trump as Deputy Assistant Secretary in the Department of the Interior and 2019, she was confirmed by the U.S. Senate as the 22nd Director of the U.S. Fish and Wildlife Service, where she led the 8500-employee agency with over 850 million acres of land and water to revolutionize business operations, improve service and grant more access to the American people. Aurelia is passionate and committed to wildlife, the environment, science, and sustainable development. In her spare time, she works on various projects, including applying new digital technologies toward conserving plants and wildlife and operating a thriving real estate rental business in Missouri, Indiana, and South Dakota. She received her Bachelor’s degree from Howard University, Master’s degree from Purdue University and law degree from University of Kentucky’s College of Law. She serves on several boards, including Ramaco Resources, a publicly-traded metallurgical coal company, Steamboat Institute, Rubicon Institute, and Ducks Unlimited’s Conservation Program Committee. Aurelia enjoys the outdoors and you will usually find her outside fishing, hunting, or running. She holds a sub-3-hour marathon time.

+
[ Conservation ADVISORY BOARD ]
 

Bioethics

Alta Charo, J.D. is the Knowles Professor Emerita of Law & Bioethics at the University of Wisconsin, where for over 30 years she has taught classes on biotechnology policy, food and drug law, public health law and bioethics. Alta is now the David A. Hamburg Inaugural Fellow at the Nuclear Threat Initiative, working in its global biosecurity program. She is also an elected member of the American Academy of Arts and Sciences; the American Association for the Advancement of Science; and the National Academy of Medicine. She was a member of Pres. Clinton’s National Bioethics Advisory Commission, worked as a policy analyst at the congressional Office of Technology Assessment and the US Agency for International Development, and also served as a senior policy advisor

in the Office of the Commissioner at the FDA, focusing on regulatory approaches to emerging technologies. At the National Academies of Sciences, Engineering and Medicine she co-chaired the committees on guidelines for embryonic stem cell research (2005-2010) and governance of human genome editing (2015-2017), co-founded the forum on regenerative medicine, served on its committee on science technology and law, and now co-chairs its standing committee on “emerging science, technology and innovation.” At present, she is also a member of the World Health Organization’s expert advisory committee on global governance of genome editing, and a member of the organizing committee for the upcoming 2022 US-UK “third international summit on genome editing.”

+
Advisors
Indigenous Council

Leadership

INDIGENOUS
COUNCIL

+

The Indigenous Council is an advisory body led by Cristina Mormorunni and Jason Baldes who are respected leaders in indigenous-led conservation, and includes conservation leaders and representatives from various Native American tribes and organizations who bring a wealth of conservation experience, knowledge, and cultural wisdom to Colossal’s work, and will continue to provide insights and guidance to the company’s initiatives.

+
QUOTE MODULE

Tribal cultures have always placed tremendous value on how the past has shaped the present. The natural world, both plants and animals have held cultural significance and heritage to tribes across the globe since the beginning of time. Civilization views conservation as something that occurs in the present. With Colossal, we now have the opportunity to bring conservation to the future by reaching into the past and marrying the worlds of conservation and cultural significance

together through the de-extinction of species. Not only do we contribute to biodiversity and conservation, we have the opportunity to reach back into the heritage of our ancestors and bring animals of great cultural and historical significance into our present lives. As great as the scientific advancement of this technology may be to the world, the cultural significance may dwarf the scientific achievement as our future ancestors look back on this inflection point in history.

- Mark N. Fox

MHA Nation Tribal Chairman

QUOTE MODULE
“We are living through a planetary crisis, which is at its root a

crisis of relationship. Renewing our connection to our more-than-

human relatives is the most important step we can all take to turn

things around, and it will take all of us. Our collaboration with

Colossal is vital to meeting this challenge, a sacred partnership

grounded in respect, reciprocity, and a shared dedication to the

power innovation, creativity, and fierce love hold in meeting the

challenges humanity and our home planet collectively face.”

- Cristina Mororunni

Indigenous Council Co-lead,
Co-Founder and Director of INDIGENOUS LED

+
+
+
Advisors Youth BOARD

Leadership

Youth Advisory Board

+
+
 
+